Monthly Service Delivery Reporting format

Sub District Hospital (SDH) FORMAT

State : __________________________________________________________________
District :________________________________________________________________
Block / Health Block : _____________________________________________________
Name of Health Institution : ________________________________________________
Facility Sub Type: _______________________ Ownership: _____Public / Private______
Number of Beds : ________ Reporting month: ____________Financial Year _________
Name & Designation of the person reported Data _______________________________
Date of reporting Data ______________________________________________________
Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
Part A REPRODUCTIVE AND CHILD HEALTH
M1 Ante Natal Care (ANC) Services & High Risk Pregnancies
1.1. Total number of NEW Pregnant Women registered for ANC

1.1.a Out of total number of NEW pregnant women registered with age <15 years

1.1.b Out of total number of NEW pregnant women registered with age 15-19 years

1.1.c Out of total number of NEW pregnant women registered with age >19 to 49 years

1.1.d Out of total number of NEW pregnant women registered with age >49 years
Out of the total NEW ANC registered, number registered within 1 st trimester (within
1.1.1.
12 weeks)
1.1.2. Total ANC footfall/cases (Old cases + New Registration) attended

1.2 ANC services

1.2.1. Number of PW given Td1 (Tetanus Diptheria dose 1)

1.2.2. Number of PW given Td2 (Tetanus Diptheria dose 2)

1.2.3. Number of PW given Td Booster (Tetanus Diptheria dose booster)

1.2.4. Number of PW provided full course 180 Iron Folic Acid (IFA) tablets

1.2.5. Number of PW provided full course 360 Calcium tablets

1.2.6. Number of PW given one Albendazole tablet after 1st trimester

1.2.7. Number of PW received 4 or more ANC check ups

1.2.8. Number of PW given ANC Corticosteroids in Pre-Term Labour

1.3 Pregnant Women (PW) with Hypertension (BP>140/90)

1.3.1. New cases of PW with hypertension detected

1.3.1.a Number of PW with hypertension managed at institution

1.3.2. Number of Eclampsia cases managed during delivery

1.4 Pregnant Women (PW) with Anaemia

Number of PW tested for Haemoglobin (Hb) 4 or more than 4 times for respective
1.4.1.
ANCs
Page 1of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
1.4.2. Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases)

1.4.3. Number of PW having Hb level<=7 g/dl (Out of total tested cases)

1.4.4. Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases)

1.5 Pregnant Women (PW) with Gestational Diabetes Mellitus (GDM)

1.5.1. Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test)

Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance
1.5.2.
Test) conducted
1.5.3. Number of PW given Insulin out of total tested positive for GDM

1.5.4. Number of PW given Metformin out of total tested positive for GDM

1.6 Pregnant Women (PW) with Syphilis

1.6.1 Syphilis test conducted for Pregnant Women

Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with
1.6.1.a
VDRL/RPR/TPHA/RDT/PoC) for Syphilis
Number of pregnant/DIL women found seropositive for Syphilis by
1.6.1.b
VDRL/RPR/TPHA/RDT/PoC test
Number of pregnant/DIL women found Syphilis-Seropositive and given treatment
1.6.1.c
with injection Benzathine Penicillin (IM)
1.6.1.d Number of live births among Syphilis seropositive Pregnant Women
Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/
1.6.1.e
clinically diagnosed for congenital Syphilis
1.6.1.f Out of above, babies with congenital Syphilis received curative treatment

1.7 Thyroid test conducted for Pregnant Women

1.7.1. Number of Pregnant Women tested positive for Thyroid disorder

1.7.2. Number of Pregnant Women treated for thyroid disorder

1.8 Tuberculosis test conducted for Pregnant Women

1.8.1. Number of Pregnant Women screened for TB

1.8.2. Number of Pregnant Women identified with Presumptive TB symptoms

Number of Pregnant Women referred out of those identified with Presumptive TB
1.8.3.
symptoms
1.9 High Risk /Complicated Pregnancies

1.9.1. Total High Risk Pregnancy (HRP) Intrapartum including following:

Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after
1.9.1.a.
delivery) in the facility
Number of Pregnant Women with Sepsis in the facility
1.9.1.b.

1.9.1.c. Number of Pregnant Women identified with Eclampsia in the facility

1.9.1.d. Number of Pregnant Women identified with obstructed labour in the facility

1.9.2. Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported)

Page 2of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
1.9.3. Total no. of ANC or PNC cases referred to Higher/ any other facility

1.9.4 Total no. of ANC or PNC cases referred in to the facility

1.9.5. Number of Complicated pregnancies treated with Blood Transfusion

M2 Deliveries
2.1 Deliveries conducted at Home

2.1.1. Number of Home Deliveries attended by

Number of Home Deliveries attended by Skill Birth Attendant(SBA)
2.1.1.a
(Doctor/Nurse/ANM)
Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA)
2.1.1.b
/Relatives/etc.)
2.1.2. Number of PW given Tablet Misoprostol during home delivery
Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of
2.1.3.
Home delivery
2.2 Number of Institutional Deliveries conducted (Including C-Sections)
Out of total institutional deliveries(excluding C-section), number of women stayed
2.2.1.
for 48 hours or more after delivery
Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-
2.2.2
Sections) conducted at night (8 PM- 8 AM)
Age wise total number of delivery (Home +Institutional) reported
2.3
(2.3.1+2.3.2+2.3.3+2.3.4)
2.3.1. Out of total number of delivery, PW with age <15 years

2.3.2. Out of total number of delivery, PW with age 15-19 years

2.3.3. Out of total number of delivery, PW with age >19-49 years

2.3.4. Out of total number of delivery, PW with age > 49 years

2.4. Number of newborns received 6 HBNC visits after Institutional Delivery

No. of identified Sick new-borns referred by ASHA to facility under HBNC
2.5.
Programme
2.6. Total number of Children received all scheduled 5 Home visits under HBYC

M3 Number of Caesarean (C-Section) deliveries

3.1. Total number of C -Section deliveries performed

3.1.1 Out of total C-sections, number performed at night (8 PM- 8 AM)

3.1.2 Out of total C-section, number of women stayed for 72 hours or more after delivery

M4 Pregnancy outcome & details of new-born/children

4.1 Pregnancy Outcome (in number)

4.1.1 Live Birth

4.1.1.a Live Birth - Male

4.1.1.b Live Birth - Female

4.1.2 Number of Pre-term newborns ( < 37 weeks of pregnancy)

Page 3of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
4.1.3 Still Birth

4.1.3.a Intrapartum (Fresh) Still Birth

4.1.3.b Antepartum (Macerated) Still Birth

4.2 Abortion (spontaneous)

4.3 Medical Termination of Pregnancy (MTP)

4.3.1 Number of MTPs conducted

4.3.1.a Surgical MTPs upto 12 weeks of pregnancy

4.3.1.b MTP more than 12 weeks of pregnancy

4.3.1.c MTPs completed through Medical methods of abortion (MMA)

4.3.2 Post-abortion/MTP Complications

4.3.2.a Total Post-abortion/MTP Complications Identified

Post-abortion/MTP complications identified (where abortions were carried out in
4.3.2.b.
facilities other than public and accredited private health facilities)
4.3.2.c. Post-abortion/MTP Complications treated

4.3.3. Number of women provided with Post-abortion/ MTP contraception

4.4 Details of Newborn children

4.4.1. Number of Newborns weighed at birth

4.4.2. Number of Newborns having weight less than 2500 gms

4.4.2.a Out of the above, number of Newborns having weight less than 1800 gms

4.4.3. Number of Newborns breast fed within 1 hour of birth

No. of Newborns discharged from the facility were exclusively breastfed till
4.4.4.
discharge
4.5. Rashtriya Bal Swasthaya Karyakram (RBSK)
Number of Newborns screened for defects at birth (as per Comprehensive Newborn
4.5.1
Screening, RBSK)
Number of Newborns identified with visible birth defects (including Neural tube
4.5.1.a defect, Down’s Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia
of the hip)
4.5.2 Number of SNCU discharged babies screened in DEIC

Number of children till age 18 years (affected with selected health conditions)
4.5.3
managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)

Number of children till age 18 years (affected with selected health conditions)
4.5.4
managed by Intervention - Surgical
M5 Anaemia Mukt Bharat
5.1 IFA Coverage
Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-
5.1.1.
lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month
Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi
5.1.2.
weekly)

Page 4of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
Number of children 5-9 years provided Weekly Iron Folic Acid (IFA Pink) tablets in
5.1.3.
a month
Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi
5.1.3.a
Centres
5.2 Anaemia- Identified & Treated

5.2.1 Beneficiaries identified with Mild and Moderate Anaemia

Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9
5.2.1.a
g/dl)
Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9
5.2.1.b
g/dl)
Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years)
5.2.1.c
having anaemia (Hb 8.1-11.9 g/dl)
5.2.2 Beneficiaries identified with Severe Anaemia
Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb
5.2.2.a
<8 g/dl)
Number of lactating mothers (of 0-6 months old child) having severe anaemia (Hb <8
5.2.2.b
g/dl)
Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years)
5.2.2.c
having severe anaemia (Hb <8 g/dl)
5.2.3 Beneficiaries diagnosed with mild and moderate Anaemia, put on treatment

5.2.3.a Number of anaemic in-school Children (5-9 years) put on treatment

5.2.3.b Number of anaemic in-school adolescent girls (10-19 years) put on treatment

5.2.3.c Number of anaemic out of school adolescent girls (10-19 years) put on treatment

5.2.3.d Number of anaemic in-school adolescent boys (10-19 years) put on treatment

5.2.3.e Number of anaemic lactating mothers (of 0-6 months old child) put on treatment
Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-
5.2.3.f
49 years) put on treatment
5.2.4 Beneficiaries diagnosed with Severe Anaemia, put on treatment
Number of lactating mothers (of 0-6 months old child) diagnosed with severe
5.2.4.a
anaemia and put on treatment
M6 Post Natal Care (PNC)
In case of home delivery, number of women receiving 1st Postpartum checkups
6.1.
within 48 hours
Number of women receiving Postpartum checkup between 48 hours and 14 days
6.2
after Institutional delivery
6.3 Number of mothers provided full course of 180 IFA tablets after delivery

6.4 Number of mothers provided full course 360 Calcium tablets after delivery

Sexually Transmitted Infections/Reproductive Tract Infections

M7
(STI/RTI) Cases
7.1 Number of new STI/RTI cases identified

7.1.1. Number of males assessed for STI/RTI

7.1.1.a Out of the above, number of males diagnosed with STI/RTI

7.1.1.b Out of the above, number of males treated for STI/RTI

Page 5of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
7.1.2. Number of females (all females) assessed for STI/RTI

7.1.2.a Out of the above, number of females (all females) diagnosed with STI/RTI

7.1.2.b Out of the above, number of females (all females) treated for STI/RTI

7.1.3. Number of H/TG assessed for STI/RTI

7.1.3.a Out of the above, number of H/TG people diagnosed with STI/RTI

7.1.3.b Out of the above, number of H/TG people treated for STI/RTI

M8 Family Planning
8.1 MALE STERILIZATION

8.1.1. Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted

8.2 FEMALE STERILIZATION

8.2.1. Number of Laparoscopic sterilizations (excluding post-abortion) conducted

Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum
8.2.2.
and post abortion) conducted
Number of Postpartum sterilizations (within 7 days of delivery by minilap or
8.2.3.
concurrent with caesarean section) conducted
Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical
8.2.4.
abortion) conducted
8.3. Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD)

8.4. Number of Postpartum (within 48 hours of delivery) IUCD insertions

Number of Post-abortion (within 12 days of Spontaneous or surgical abortion) IUCD
8.5.
insertions
8.6. Number of IUCD Removals

8.7. Number of complications following IUCD Insertion

8.8. Injectable Contraceptive MPA- First Dose

8.9. Injectable Contraceptive MPA- Second Dose

8.10. Injectable Contraceptive MPA- Third Dose

8.11. Injectable Contraceptive MPA- Fourth and above Dose

8.12 Number of Combined Oral Pill cycles distributed to the beneficiary

8.13. Number of Condom pieces distributed to the beneficiary

8.14. Number of Centchroman (weekly) pill strips distributed to the beneficiary

8.15. Number of Emergency Contraceptive Pills (ECP) given to the beneficiary

8.16. Number of Pregnancy Test Kits (PTK) utilized

8.17 Quality in sterilization services

8.17.1 Complications following male sterilization

8.17.2 Complications following female sterilization

8.17.3 Failures following male sterilization

8.17.4 Failures following female sterilization

Page 6of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
8.17.5 Deaths following male sterilization

8.17.6 Deaths following female sterilization

8.18 Follow up in Sterilization

Number of cases of Female Sterilization followed up (after 1 month or on the
8.18.1
resumption of her menstrual cycle whichever is earlier)
8.18.2 Number of cases of Male Sterilization followed up (after 3 months)

M9 CHILD IMMUNISATION
9.1 Number of Infants 0 to 11 months old who received:

9.1.1. Child immunisation - Vitamin K (Birth Dose)

9.1.2. Child immunisation - BCG

9.1.3. Child immunisation - Pentavalent 1

9.1.4. Child immunisation - Pentavalent 2

9.1.5. Child immunisation - Pentavalent 3

9.1.6. Child immunisation - OPV 0 (Birth Dose)

9.1.7. Child immunisation - OPV1

9.1.8. Child immunisation - OPV2

9.1.9. Child immunisation - OPV3

9.1.10. Child immunisation - Hepatitis-B0 (Birth Dose)

9.1.11. Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1)

9.1.12. Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2)

9.1.13. Child immunisation - Rotavirus 1

9.1.14. Child immunisation - Rotavirus 2

9.1.15. Child immunisation - Rotavirus 3

9.1.16. Child immunisation - PCV1

9.1.17. Child immunisation - PCV2

9.2 Number of Children 9-11 months who received:

9.2.1. Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3)

Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing
9.2.2.
vaccine(MCV) - 1st Dose
9.2.3. Child immunisation (9-11months) - JE 1st dose

9.2.4. Child immunisation - PCV Booster

Number of children aged between 9 and <12 months FULLY IMMUNIZED {BCG
9.2.5
+OPV123+ Pentavalent123+ MR/ Measles Containing Vaccine (MCV)-1st Dose}

9.2.5.a FULLY IMMUNIZED children aged between 9 and <12 months- Male

9.2.5.b FULLY IMMUNIZED children aged between 9 and <12 months- Female

Page 7of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
9.3 Children given following vaccination after 12 months (delayed vaccinations)
Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella
9.3.1.
(MR)/Measles containing vaccine(MCV)- 1st Dose
9.3.2. Child immunisation (after 12 months-delayed vaccination) - JE 1st dose

9.3.3. Child immunisation - DPT 1 after 12 months of age (delayed vaccination)

9.3.4. Child immunisation - DPT 2 after 12 months of age (delayed vaccination)

9.3.5. Child immunisation - DPT 3 after 12 months of age (delayed vaccination)

9.3.6. Child immunisation - DPT Booster after 24 months of age (delayed vaccination)

9.3.7. Child immunisation - OPV Booster after 24 months of age (delayed vaccination)

9.3.8. Child immunisation - JE Booster after 24 months of age (delayed vaccination)

9.4 Number of Children more than 12 months who received:

Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)-
9.4.1.
2nd Dose (16-24 months)
9.4.2. Child immunisation - DPT 1st Booster

9.4.3. Child immunisation - OPV Booster

Number of children more than 16 months of age who received Japanese Encephalitis
9.4.4.
(JE) vaccine- 2nd dose (16-24 months)
9.5 Number of Children more than 23 months who received:

9.5.1. Child Immunization- Typhoid

9.5.2. Children more than 5 years received DPT5 (2nd Booster)

9.5.3. Children more than 10 years received Td10 (Tetanus Diptheria10)

9.5.4. Children more than 16 years received Td16 (Tetanus Diptheria16)

9.6 Adverse Event Following Immunisation (AEFI)

9.6.1. Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)
Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring
9.6.2.
hospitalization etc.)

9.6.3. Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)

9.6.3.a Out of Number of cases of AEFI - Serious , total number of AEFI deaths

9.7 Number of Immunisation sessions

9.7.1. Immunisation sessions planned

9.7.2. Immunisation sessions held

9.8 Children received Vitamin A Doses between 9 months and 5 years

9.8.1. Child immunisation - Vitamin A Dose - 1

9.8.2. Child immunisation - Vitamin A Dose - 5

9.8.3. Child immunisation - Vitamin A Dose - 9

Page 8of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
M10 Number of cases of Childhood Diseases
New Cases of Childhood Diseases (0-5 years) & Leprosy (0-14 years)
10.1
Include new cases of OPD/IPD/Emenrgency
10.1.1. Childhood Diseases - Pneumonia

10.1.2. Childhood Diseases - Asthma

10.1.3. Childhood Diseases - Sepsis

10.1.4. Childhood Diseases - Diphtheria

10.1.5. Childhood Diseases - Pertussis

10.1.6. Childhood Diseases - Tetanus Neonatorum

10.1.7. Childhood Diseases - Tuberculosis (TB)

10.1.8. Childhood Diseases - Acute Flaccid Paralysis(AFP)

10.1.9. Childhood Diseases - Measles

10.1.10. Childhood Diseases - Malaria

10.1.11. Childhood Diseases - Diarrhoea

10.1.12. Childhood Diseases - Diarrhoea treated with ORS

10.1.13. Childhood Diseases - Diarrhoea treated with Zinc for 14 days

10.1.14. Childhood Diseases -Leprosy Cases

10.1.15. Childhood Diseases- Leprosy with Grade II disability

10.2 Childhood IPD

10.2.1. Children admitted with Respiratory Infections

10.2.2. Children admitted with Pneumonia

10.2.3. Children admitted with Diarrhoea

Part B National Programmes

M11 National Vector Borne Disease Control Programme (NVBDCP)

11.1 Malaria
11.1.1 Microscopy Tests

11.1.1.a Total Blood Smears Examined for Malaria

11.1.1.b Malaria (Microscopy Tests ) - Plasmodium Vivax test positive

11.1.1.c Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive

11.1.1.d Malaria (Microscopy Tests ) - Mixed test positive

11.1.2 Rapid Diagnostic Test (RDT )

11.1.2.a RDT conducted for Malaria

11.1.2.b Malaria (RDT) - Plasmodium Vivax test positive

11.1.2.c Malaria (RDT) - Plasmodium Falciparum test positive

11.1.2.d Malaria (RDT) - Mixed test positive

Page 9of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
11.2 Kala Azar- Rapid Diagnostic Test (RDT)

11.2.1. Kala Azar (RDT) - Tests Conducted

11.2.2. Kala Azar Positive Cases

11.3 Dengue & Chikungunya

11.3.1. Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted

11.3.2. Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive

11.3.3. Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted

11.3.4. Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive

11.4 Acute Encephelitis Syndrome/ Japanese Encephalitis (AES/ JE)

11.4.1. No. of AES cases tested for JE(IgM ELISA)

11.4.2. No. of JE positive cases

11.5 Lymphatic Filaraisis

Number of persons that consumed MDA(Mass Drug Administration) drugs during
11.5.1.
the MDA round
Number of Lymphatic Filarisis lymphoedema patients received MMDP (Morbidity
11.5.2.
Management And Disability Prevention) kits
11.5.3. Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP)

M12 Adolescent Health

12.1. Adolescent Friendly Health Clinics (AFHCs)
Number of Adolescents (10-19 years) registered in Adolescent Friendly Health
12.1.1
Clinic (AFHC)
12.1.1.a Girls registered in AFHC

12.1.1.b Boys registered in AFHC

12.1.2. Out of registered adolescents (10-19 years), number received clinical services

12.1.2.a Out of Girls registered, Girls received clinical services

12.1.2.b Out of Boys registered, Boys received clinical services

12.1.3. Out of registered adolescents (10-19 years), number received counselling

12.1.3.a Out of Girls registered, Girls received counselling

12.1.3.b Out of Boys registered, Boys received counselling

12.2 Coverage under MHS- Menstrual Hygiene Scheme (GOI supported)

12.2.1 Number of adolescent girls provided sanitary napkin packs by ASHA

12.2.2 Number of sanitary napkin packs distributed free to ASHA (for her personal use)

12.2.3 Number of adolescent girls attended monthly meeting

Number of adolescent girls provided sanitary napkin packs by State/UT supported
12.2.4
Menstrual Hygiene Scheme (MHS)

Page 10of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
12.3 Peer Educator Programme
12.3.1. Number of Adolescent Health & Wellness Days organized

M13 National TB Elimination Programme (NTEP)

13.1. Number of notified TB patients who are on Anti Tuberculosis Therapy

13.2. Number of Presumptive TB (ie with 4 Symptom complex of TB) identified

Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent
13.3.
for any TB testing
Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent
13.3.a
for any TB testing within the facility
Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent
13.3.b
for any TB testing outside the facility
Of the number sent for testing, number who were tested (by any test) for TB within
13.4.
the facility
Of the number sent for testing, number who were tested (by any test) for TB outside
13.5.
the facility
13.6. Of the number tested, number of persons diagnosed as TB patients.
Number of TB patients availing treatment through a Treatment supporter for the
13.7.
reporting month
13.8. Number of beneficiaries who are registered at the ICTC centre.
Of the number registered at ICTC centre, the number of presumptive TB cases
13.9.
identified and referred for TB testing and diagnosis.
Number of Directly Observed Treatment, Short-course (DOTS) cases completed
13.10.
successfully
Part C. Health Facility Services
M.14 Patient Services
Out Patient Department (OPD in Facility) by disease/ health condition
14.1
(excluding teleconsultation)
14.1.1. Outpatient - Diabetes

14.1.2. Outpatient - Hypertension

14.1.3. Outpatient - Stroke (Paralysis)

14.1.4. Outpatient - Cardiovascular Disease

14.1.5. Outpatient - Mental illness

14.1.6. Outpatient - Epilepsy

14.1.7. Outpatient - Ophthalmic Related

14.1.8. Outpatient - Dental

14.1.9. Outpatient - ENT

14.1.10. Outpatients- Asthma

14.1.11. Outpatient - Oral Cancer

14.1.12. Outpatient - Breast Cancer

14.1.13. Outpatient - Cervical Cancer

14.1.14. Outpatient - Other Cancer

Page 11of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
14.1.15. Outpatient - COPD

14.1.16. Outpatient - CKD (Chronic Kidney Disease)

14.1.17. Outpatient- Patients undergoing refraction

14.1.18. Outpatient - Tuberculosis

14.1.19. Outpatient – Leprosy Cases

14.1.20. Outpatient – Leprosy with Grade II disability

14.1.21. Outpatient – Geriatric

14.1.22. Outpatient - Chronic Liver Disease

14.1.23. Outpatient - Palliative Care

14.1.24. Other Services

14.1.24.a Number of patients provided physiotherapy services

14.1.24.b Number of Palliative Patients visited at home

14.2 Outpatient attendance (All) (excluding teleconsultation)

14.2.1. Allopathic- Outpatient attendance

14.2.2. Ayush - Outpatient attendance

14.3 Inpatient details

14.3.1 IPD Admission

14.3.1.a IPD Admission Male- Children<18yrs

14.3.1.b IPD Admission Male- Adults <65yrs

14.3.1.c IPD Admission Female- Children<18yrs

14.3.1.d IPD Admission Female- Adults<65yrs

14.3.1.e IPD Admission Geriatric->=65yrs

14.3.2 IPD Discharge

14.3.2.a IPD Discharge Male- Children<18yrs

14.3.2.b IPD Discharge Male- Adults<65yrs

14.3.2.c IPD Discharge Female- Children<18yrs

14.3.2.d IPD Discharge Female- Adults<65yrs

14.3.2.e IPD Discharge Geriatric->=65yrs

14.3.3 IPD Referred Out

14.3.3.a IPD Referred Male- Children<18yrs

14.3.3.b IPD Referred Male- Adults<65yrs

14.3.3.c IPD Referred Female- Children<18yrs

14.3.3.d IPD Referred Female- Adults<65yrs

14.3.3.e IPD Referred Geriatric->=65yrs

Page 12of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
IPD Deaths (excluding deaths at Emergency department & Sick Newborn Care Unit
14.3.4
(SNCU)
14.3.4.a IPD Deaths Male- Children<18yrs

14.3.4.b IPD Deaths Male- Adults<65yrs

14.3.4.c IPD Deaths Female- Children<18yrs

14.3.4.d IPD Deaths Female- Adults<65yrs

14.3.4.e IPD Deaths Geriatric->=65yrs

14.3.5 Total Number of cases Referred out (OPD+IPD+Emergency)

14.3.5.a Total cases Referred out (OPD+IPD+Emergency)-During Day

14.3.5.b Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM)

14.3.6 Day Care Admissions

14.3.7 Number of Left Against Medical Advice (LAMA) cases

14.3.7.a Number of Total Left Against Medical Advice (LAMA) cases reported at the facility

14.3.7.b Number of delivery LAMA cases reported at the facility

14.3.8 Total number of Medico Legal Cases reported at the facility

14.3.9 Total number of postmortem conducted at the facility

14.3.10 Total number of telemedicine consultation provided

14.4 Inpatient by disease/ health condition

14.4.1 Inpatient - Malaria

14.4.2 Inpatient - Dengue

14.4.3 Inpatient - Typhoid

Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory
14.4.4
infections
14.4.5 Inpatient - Tuberculosis

14.4.6 Inpatient - Pyrexia of unknown origin (PUO)

14.4.7 Inpatient - Diarrhoea with dehydration

14.4.8 Inpatient – Leprosy (Reconstructive Surgery)

14.4.9 Inpatient – Operated for Cataract

14.4.10 Inpatient – Palliative Care

14.5. Emergency
14.5.1 Patients registered at Emergency Department

14.5.2 No. of Emergencies managed at night (8 PM- 8 AM)

14.6 Emergency admissions/deaths due to

14.6.1.a Emergency - Trauma ( accident, injury, poisoning etc) -Admission

14.6.1.b Emergency - Trauma ( accident, injury, poisoning etc) -Deaths

Page 13of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
14.6.2.a Emergency - Burn -Admission

14.6.2.b Emergency - Burn -Deaths

14.6.3.a Emergency - Obstetrics complications -Admission

14.6.3.b Emergency - Obstetrics complications -Deaths

14.6.4.a Emergency - Snake Bite -Admission

14.6.4.b Emergency - Snake Bite -Deaths

14.6.5.a Emergency - Acute Cardiac Emergencies -Admission

14.6.5.b Emergency - Acute Cardiac Emergencies -Deaths

14.6.6.a Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission

14.6.6.b Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths

14.6.7.a Emergency - Dog Bite -Admission

14.6.7.b Emergency - Dog Bite -Deaths

14.7 Total number of deaths occurring at Emergency Department

14.8 Operations (excluding C-section)

Total number of Major Operations conducted excluding C-Section (General and
14.8.1.a
spinal anaesthesia)
14.8.1.b Out of Major Operation, Gynecology- Hysterectomy surgeries

14.8.1.c Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.

14.8.1.d No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section)

14.8.2. Minor Operations (No or local anaesthesia)

14.8.3. Number of post operative Surgical Site infection

14.9 Blood Units(Issued/Transfused) during Operations (excluding C-section)

14.9.1 Number of blood units issued for Operations (excluding C-section)

14.9.2 Number of blood transfusions done during Operations (excluding C-section)

14.10 In-Patient Head Count at midnight

14.11 Sick Newborns (up to 4 weeks) Admissions

14.11.1 Number of Admission in NBSU ( New Born Stabilisation Unit)

14.11.2 Special Newborn Care Unit (SNCU Admissions) - Inborn Male

14.11.3 Special Newborn Care Unit (SNCU Admissions) - Inborn Female

14.11.4 Special Newborn Care Unit (SNCU Admissions) Outborn – Male

14.11.5 Special Newborn Care Unit (SNCU Admissions) Outborn - Female

14.11.6 Special Newborn Care Unit (SNCU Admissions) - referred by ASHA

14.12 SNCU(Deaths & Discharge)

14.12.1 Number of deaths occurred at SNCU

14.12.2 Number of Newborns successfully discharged from SNCU

Page 14of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
14.13 Janani Shishu Suraksha Karyakram (JSSK)
Number of Pregnant Women(PW) and Post Natal Care (PNC) Beneficiaries
14.13.1
provided
14.13.1.a Total number of PW and PNC - JSSK Beneficiaries

14.13.1.b Number of PW and PNC benificiaries provided - Free Medicines under JSSK

14.13.1.c Number of PW and PNC benificiaries provided - Free Diet under JSSK

14.13.1.d Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK
Number of PW and PNC benificiaries provided - Free Home to facility transport
14.13.1.e
under JSSK
Number of PW and PNC benificiaries provided - Interfacility transfers when needed
14.13.1.f
under JSSK
14.13.1.g Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK

14.13.1.h Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK

14.13.2 Number of sick infants provided

14.13.2.a Number of infants admitted at facility due to any sickness- JSSK Beneficiaries

14.13.2.b Number of sick infants provided - Free Medicines under JSSK

14.13.2.c Number of sick infants provided - Free Diagnostics under JSSK

14.13.2.d Number of sick infants provided - Free Home to facility transport under JSSK

14.13.2.e Number of sick infants provided - Interfacility transfers when needed under JSSK

14.13.2.f Number of sick infants provided - Free Drop Back home under JSSK

14.13.2.g Number of sick infants provided - Free Blood transfusion under JSSK

14.14 Nutritional Rehabilitation Centre (NRC)

14.14.1. Number of sick SAM children admitted in standalone/ integrated NRC

Number of sick SAM children referred to standalone/ integrated NRC by Frontline
14.14.2.
Workers (AWW/ ASHA/ ANM)
Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD
14.14.3.
of other Health Facility (PHC/CHC/SDH/DH/other NRC)
14.14.4. Number of children Referred to standalone/ integrated NRC by RBSK Team
Number of SAM children discharged from standalone/ integrated NRC who met the
14.14.5.
discharge criteria
14.14.6. Number of admitted children left against medical advice (LAMA) / defaulter

14.14.7. Number of children died while admitted in standalone/ intergrated NRC

14.14.8. Number of children who completed all four post discharge follow-ups
Number of sick SAM children treated and admitted in the pediatric facility (other
14.14.9.
than standalone/ integrated NRC)
14.14.10. In-Patient Head Count at midnight for standalone/ integrated NRC

14.15. Number of Rogi Kalyan Samiti (RKS) meetings held

Number of Anganwadi centres reported to have conducted atleast one Village

14.16
Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions

Page 15of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
14.17 Total number of UHND/VHND sessions conducted in the reporting month
Total number of Outreach/Special Outreach camps conducted in the reporting
14.18
month
14.19. Stock outs

14.19.a Stock out rate of essential Drugs

14.19.b Total no. of essential drugs for which stock-outs reported

Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor)
14.20.
to be considered as replacement donations}
14.21. Total number of blood units issued in month

14.22. PM National Dialysis Programme (PMNDP)

14.22.1 Hemo-dialysis Services under PMNDP
Number of patients registered for hemodialysis services in the centre during the
14.22.1.a
reporting month
Number of patients on waiting list for hemodialysis services at the end of reporting
14.22.1.b
month
14.22.1.c Number of hemodialysis sessions held during the reporting month

14.22.2 Peritoneal Dialysis services under PMNDP

Number of patients started Peritoneal dialysis under PMNDP during the reporting
14.22.2.a
month
National Viral Hepatitis Control Program (Diagnosis and Management of viral
14.23.
hepatitis)
14.23.1 Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis
Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e.
14.23.1.a
HBsAg (excluding pregnant women)
Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis
14.23.1.b
C(Anti- HCV)
Total number of blood samples tested positive by ELISA/ Rapid tests for viral
14.23.2
hepatitis & its management
Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B
14.23.2.a
(out of those tested for HBsAg excluding pregnant women)
Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested
14.23.2.a.i
for HBV DNA(out of those tested positive for HBsAg excluding pregnant women)
14.23.2.a.i
Total number of patients found positive for HBsAg eligible for treatment for
i hepatitis B (excluding pregnant women)
14.23.2.a.i
Total number of patients eligible for treatment for Hepatitis B put on treatment(out
ii of those eligible for treatment excluding pregnant women)
Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C
14.23.2.b
(out of those tested for Anti-HCV)
Total number of positive blood samples for Hepatitis C screened by test (ELISA/
14.23.2.b.i
Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV)
14.23.2.b.i Total number of patients put on treatment for Hepatitis C (out of those confirmed
i by HCV RNA i.e. HCV RNA detected)
14.23.2.b.i
Total number of positive Hepatitis C patients who have completed treatment
ii
14.23.2.b.i Total number of patients cleared for HCV RNA on sustained virological response at
v 12 weeks (SVR12)

Page 16of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
14.23.3 Hepatitis B in pregnancy

14.23.3.a Number of Pregnant Women tested for HBsAg

Number of Pregnant Women who are HBsAg positive(out of those tested for
14.23.3.b
Hepatitis B i.e. HBsAg)
Number of Pregnant Women found positive for HBsAg referred out to higher centre
14.23.3.c
for institutional delivery
14.23.3.d Number of Pregnant Women found positive for HBsAg delivered in an institution
Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg
14.23.3.e
positive pregnant women
Number of New Borns to Pregnant Women (found positive for HBsAg) received
14.23.3.f
Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth)
M15 Laboratory Testing
15.1 Total Number of Lab Tests

15.1.1 Total Number of Lab Tests done- Inhouse

15.1.2 Total Number of Lab Tests done- Outsourced

15.2 Hb Tests Conducted

15.2.1 Number of Hb tests conducted including kit tests

15.2.2 Out of the total number of Hb tests done, Number having Hb < 7 mg

15.3 HIV tests

15.3.1.a Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test

15.3.1.b Out of the above, No. of males found reactive for HIV
No. of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-
15.3.1.c
ICTC)
15.3.1.d Out of the above, No. of males confirmed as HIV Positive
Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT
15.3.2.a
test/POC test
15.3.2.b Out of the above, No. of females (non-ANC) found reactive for HIV
No. of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre
15.3.2.c
(Stand Alone-ICTC)
15.3.2.d Out of the above, No. of females (non-ANC) confirmed as HIV Positive
Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger
15.3.3.a
Prick/RDT test/POC test
15.3.3.b Out of the above, No. of PW(ANC) found reactive for HIV
No. of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand
15.3.3.c
Alone-ICTC)
15.3.3.d Out of the above, No. of PW(ANC) confirmed as HIV Positive
Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC
15.3.3.e
test
15.3.3.f Out of the above, No. of DIL women found reactive for HIV
No. of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand
15.3.3.g
Alone-ICTC)

Page 17of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
15.3.3.h Out of the above, No. of DIL women confirmed as HIV Positive
Number of Pregnant Women (ANC&DIL) screened for HIV more than
15.3.3.i
once(Repeated testing)
Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC
15.3.4.a
test
15.3.4.b Out of the above, No. of H/TG people found reactive for HIV
No. of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand
15.3.4.c
Alone-ICTC)
15.3.4.d Out of the above, No. of H/TG people confirmed as HIV Positive

15.4 STI/RTI attendees Tested for Syphilis

15.4.1.a Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA)

Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/
15.4.1.b
RDT/TPHA)
15.4.1.c Out of the above, number of males treated for Syphilis

15.4.2.a Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA)

Out of the above, number of females (non-ANC) tested reactive for Syphilis
15.4.2.b
(RPR/VDRL/PoC/ RDT/TPHA)
15.4.2.c Out of the above, number of females (non-ANC) treated for Syphilis

15.4.3.a Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA)
Out of the above, number of H/TG people tested reactive for Syphilis
15.4.3.b
(RPR/VDRL/PoC/ RDT/TPHA)
15.4.3.c Out of the above, number of H/TG people treated for Syphilis

15.5 Widal tests

15.5.1 Widal tests- Number Tested

15.5.2 Widal tests- Number Positive

15.6 Diagnostics Tests conducted

15.6.1 Radiology

15.6.1.a.i X-ray(Inhouse)

15.6.1.a.ii X-ray(Outsource)

15.6.1.b.i Ultrasonography (USG) (Inhouse)

15.6.1.b.ii Ultrasonography (USG)(Outsource)

15.6.1.c.i CT scan (Inhouse)

15.6.1.c.ii CT scan (Outsource)

15.6.1.d.i MRI (Inhouse)

15.6.1.d.ii MRI (Outsource)

15.6.1.e.i ECG (Inhouse)

15.6.1.e.ii ECG (Outsource)

Page 18of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
Part D. Mortality Details
M16 Details of deaths reported:
New Born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to
16.1.1.a
facility in transit
New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at
16.1.1.b
home or home to facility transit)
16.1.2.a New Born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit
New born deaths within 1 week (1 to 7 days) At Community (at home or home to
16.1.2.b
facility transit)
16.1.3.a New Born deaths within 8 to 28 days at Facility/Facility to facility in transit
New born deaths within 8 to 28 days At Community (at home or home to facility
16.1.3.b
transit)
16.1.4.a Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit
Infant Deaths (>28 days to 12 months) At Community (at home or home to facility
16.1.4.b
transit)
16.2 Neonatal Deaths up to 4 weeks (0 to 28 days) due to

16.2.1. Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis

16.2.2. Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia

16.2.3. Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity

16.2.4. Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes

16.3 Infant Deaths Between more than 28 days and less than 12 months due to

16.3.1. Number of Infant Deaths (>28 days -12 months) due to Pneumonia

16.3.2. Number of Infant Deaths (>28 days -12 months) due to Diarrhoea

16.3.3. Number of Infant Deaths (>28 days -12 months) due to Fever related

16.3.4. Number of Infant Deaths (>28 days -12 months) due to Measles

16.3.5. Number of Infant Deaths (>28 days -12 months) due to Others

16.4 Child Deaths between 1 year and less than 5 years due to

16.4.1. Number of Child Deaths (1 -5 years) due to Pneumonia

16.4.2. Number of Child Deaths (1 -5 years) due to Diarrhoea

16.4.3. Number of Child Deaths (1 -5 years) due to Fever related

16.4.4. Number of Child Deaths (1 -5 years) due to Measles

16.4.5. Number of Child Deaths (1 -5 years) due to Others

16.5 Maternal Deaths due to

16.5.1. Number of Maternal Deaths due to APH (Antepartum Haemmorhage)

16.5.2. Number of Maternal Deaths due to PPH (Post-partum Haemmorhage)

16.5.3. Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever

16.5.4. Number of Maternal Deaths due to Abortive complication

Page 19of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
16.5.5. Number of Maternal Deaths due to Obstructed/prolonged labour
Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive
16.5.6.
disorder in pregnancy, birth and puerperium
16.5.7. Number of Maternal Deaths due to Other/Unknown Causes
16.5.8. Age wise total Maternal Deaths, occurred at Facility

16.5.8.a Out of total number of maternal deaths, deaths with age<15 years

16.5.8.b Out of total number of maternal deaths, deaths with age 15-19 years

16.5.8.c Out of total number maternal deaths, deaths with age more than >19-49 years

16.5.8.d Out of total number maternal deaths, deaths with age more than >49 years

16.6. Total Facility Based Maternal Death Reviews (FBMDR) done

16.7 Other Deaths (except Infant, Child & Maternal Deaths) 5 years and above due to

16.7.1. Number of deaths due to Diarrhoeal diseases

16.7.2. Number of deaths due to Tuberculosis

16.7.3. Number of deaths due to Respiratory diseases including infections (other than TB)

16.7.4. Number of deaths due to Other Fever Related

16.7.5. Number of deaths due to Heart disease/Hypertension related

16.7.6. Number of deaths due to Cancer

16.7.7. Number of deaths due to Neurological disease including strokes

16.7.8. Number of deaths due to Accidents/Burn cases

16.7.9. Number of deaths due to Self Harm

16.7.10. Number of deaths due to Animal bites and stings

16.7.11. Number of deaths due to Known Acute Disease

16.7.12. Number of deaths due to Known Chronic Disease

16.7.13. Number of deaths due to Other Causes

16.8 Deaths due to Vector Borne Diseases ( all age groups)

16.8.1. Number of Deaths due to Malaria- Plasmodium Vivax

16.8.2. Number of Deaths due to Malaria- Plasmodium Falciparum

16.8.3. Number of Deaths due to Kala Azar

16.8.4. Number of Deaths due to Dengue

16.8.5. Number of Deaths due to Acute Encephelitis Syndrome (AES)

16.8.6. Number of Deaths due to Japanese Encephalitis (JE)

16.9 Total Deaths (above 5 years of age)

16.9.1 Above 5 years to below 10 years

16.9.2 Above 10 years to below 19 years

16.9.3 Adult above >19 years

Page 20of 21
 Numbers Numbers
Facility reported during reported during
Data Item
Code the month the month
(In-facility) (Outreach)
Part E. Quality Control
QA (Quality Assurance) & BEMMP (Biomedical Equipment
M.17
Management & Maintenance Program)
17.1 EQAS Compliance
Total number of Haematology tests registered under External Quality Assurance
17.1.1.
Scheme (EQAS)
17.1.2. No. of registered Haematology tests reported EQAS Compliant
Total number of Biochemistry tests registered under External Quality Assurance
17.1.3.
Scheme (EQAS)
17.1.4. No. of registered Bio chemistry tests report EQAS Compliant
Total Quantity of Bio medical waste generated in Kg for the month - (All Yellow,
17.1.5.
Red, white & Blue)
17.1.6. Total Quantity of General waste generated in Kg for the month

17.2 Biomedical Equipment Management & Maintenance Program

17.2.1. Total number of breakdown calls reported for the month

17.2.2. Total number of breakdown attended for the month

17.2.3. Number of visit made by the service engineer/ BME for the month
Updated as on 18-08-2023

Signature of report compiler Signature of Facility Incharge

Date : _____________ Date: ______________

Page 21of 21